LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling

J Tang, Y Li, Y Sang, B Yu, D Lv, W Zhang, H Feng - Oncogene, 2018 - nature.com
Recent molecularly targeted approach gains advance in breast cancer treatment. However,
the estimated 5-year survival rate has not met the desired expectation for improvement …
被引用次数：145 相关文章

LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling

J Tang, Y Li, Y Sang, B Yu, D Lv, W Zhang, H Feng - Oncogene, 2018 - go.gale.com
Recent molecularly targeted approach gains advance in breast cancer treatment. However,
the estimated 5-year survival rate has not met the desired expectation for improvement …

LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling.

J Tang, Y Li, Y Sang, B Yu, D Lv, W Zhang, H Feng - Oncogene, 2018 - europepmc.org
Recent molecularly targeted approach gains advance in breast cancer treatment. However,
the estimated 5-year survival rate has not met the desired expectation for improvement …
[PDF] researchgate.net

[PDF][PDF] LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling

J Tang, Y Li, Y Sang, B Yu, D Lv, W Zhang, H Feng - 2018 - researchgate.net
Recent molecularly targeted approach gains advance in breast cancer treatment. However,
the estimated 5-year survival rate has not met the desired expectation for improvement …

LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling

J Tang, Y Li, Y Sang, B Yu, D Lv, W Zhang… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Recent molecularly targeted approach gains advance in breast cancer treatment. However,
the estimated 5-year survival rate has not met the desired expectation for improvement …